JANET SCHWARTZENBERG: Open Payments
NPI 1194767640 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,055 in 196 payments from 24 companies in 2025. Trend: 2023 $3,045 · 2024 $5,080 · 2025 $4,055
Food & beverage: $3,937Education: $118
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 32 | $541 |
| ABBVIE INC. | 22 | $462 |
| UCB, Inc. | 20 | $434 |
| GlaxoSmithKline, LLC. | 17 | $410 |
| AstraZeneca Pharmaceuticals LP | 18 | $328 |
| Novartis Pharmaceuticals Corporation | 9 | $247 |
| Janssen Scientific Affairs, LLC | 2 | $192 |
| E.R. Squibb & Sons, L.L.C. | 15 | $179 |
| PFIZER INC. | 8 | $148 |
| Janssen Biotech, Inc. | 5 | $140 |
Products named: Bimzelx, BENLYSTA, SAPHNELO, TREMFYA, SKYRIZI, COSENTYX, ORENCIA, KRYSTEXXA.
Industry payments across TX — which companies pay providers there.
